Secondary Combined Immunodeficiency in Pediatric Patients after the Fontan Operation: Three Case Reports

Eva Hlavackova1, Martin Liska, Hana Jicinska

  • 1Department of Clinical Immunology and Allergology, St. Anne's University Hospital, Brno, Czech Republic.

Insights

Patients undergoing the Fontan operation may develop protein-losing enteropathy (PLE), leading to secondary immunodeficiency. Regular immunological follow-up is crucial for managing these complex cardiac patients.

Area of Science:

  • Cardiology
  • Immunology
  • Pediatrics

Background:

  • The Fontan operation (total cavopulmonal connection, TCPC) is a palliative surgery for complex congenital heart defects with univentricular circulation.
  • Protein-losing enteropathy (PLE) affects 4-13% of patients post-Fontan, causing secondary combined immunodeficiency.
  • This immunodeficiency is characterized by hypogammaglobulinemia and CD4+ lymphocytopenia.

Observation:

  • Three case reports detail secondary immunodeficiency in patients post-Fontan operation.
  • Hypogammaglobulinemia severity correlated with infectious complications, but severe T cell deficiency was not observed.
  • Immunoglobulin replacement and antibiotic prophylaxis mitigated clinical consequences.

Findings:

  • Heart transplantation resolved PLE and restored IgG levels in one patient.
  • Immunological follow-up was delayed in all reported cases.
  • Secondary immunodeficiency post-Fontan operation is a significant concern.

Implications:

  • Regular clinical immunologist follow-up is recommended for all patients after Fontan surgery.
  • Early detection and management of immunodeficiency can improve outcomes.
  • Understanding the immunological sequelae of Fontan palliation is vital for long-term patient care.